Supha Pharmachem Limited (BOM:539561)
India · Delayed Price · Currency is INR 0.2600
-0.0100 (-3.70%)
At close: Sep 11, 2026
Supha Pharmachem Market Cap
Supha Pharmachem has a market cap or net worth of 104.83 million as of September 11, 2026. Its market cap has decreased by -82.31% in one year.
Market Cap
104.83M
Enterprise Value
10.97B
Revenue
5.27B
Ranking
n/a
PE Ratio
1.39
Stock Price
0.26
ChartMarket Cap Chart
Since May 25, 2018, Supha Pharmachem's market cap has increased from 45.36M to 104.83M, an increase of 131.11%. That is a compound annual growth rate of 10.61%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 104.83M | -65.33% |
| Dec 31, 2025 | 302.40M | -85.35% |
| Dec 31, 2024 | 2.06B | -79.58% |
| Dec 29, 2023 | 10.11B | 1,895.62% |
| Dec 30, 2022 | 506.52M | 1.22% |
| Dec 31, 2021 | 500.40M | 194.18% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| May 25, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Kimia Biosciences | 1.40B |
| Panchsheel Organics | 1.39B |
| Krebs Biochemicals & Industries | 1.29B |
| Tyche Industries | 1.15B |
| Vasundhara Rasayans | 461.47M |
| Crestchem | 406.50M |
| Alfavision Overseas (India) | 397.86M |
| Bacil Pharma | 254.05M |